ks1490
Well-known member
Hi,
I would be interested in people's opinion on one line that stood out for me in the University of Cologne study that is mentioned in the recent "St. Jude or On-X" thread. The quote is: "Late adverse event rates were low, most notably thromboembolism (0.9%/pt-yr after AVR; 1.6%/pt-yr after MVR) and thrombosis." If the chances of a thromboembolic event is about 1% per year, doesn't that mean that after 20-30 years, your chance of some nasty event is now 20-30%? I'm wondering how people felt about that and how it may have figured into your decision to go tissue vs. mechanical. If the mortality rate for a re-op in the next 15 years is only a few percent, doesn't that outweigh the higher percentage risk of a coumadin-related event?
Thanks for your thoughts.
I would be interested in people's opinion on one line that stood out for me in the University of Cologne study that is mentioned in the recent "St. Jude or On-X" thread. The quote is: "Late adverse event rates were low, most notably thromboembolism (0.9%/pt-yr after AVR; 1.6%/pt-yr after MVR) and thrombosis." If the chances of a thromboembolic event is about 1% per year, doesn't that mean that after 20-30 years, your chance of some nasty event is now 20-30%? I'm wondering how people felt about that and how it may have figured into your decision to go tissue vs. mechanical. If the mortality rate for a re-op in the next 15 years is only a few percent, doesn't that outweigh the higher percentage risk of a coumadin-related event?
Thanks for your thoughts.